Schedule 13G ownership disclosure
GLYCOMIMETICS INC
Security class unavailable · CUSIP: 38000Q102
Event date: 2020-03-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 4,831,896
- Percent of class
- 11.0900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902219-20-000372
- Form type
- SC 13G
- Filer
- CRESCENT BIOPHARMA, INC.
- CIK
- CIK 1253689
- Filed
- Apr 09, 2020
- Reporting period
- Mar 31, 2020
- Description
- Schedule 13G beneficial ownership